Development of a Cure for Diabetes and its Complications in Pets

What are the current challenges in treating diabetes in pets?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications in Pets, Englsih|

Will the new drug be administered orally or via intravenous injection?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Development of a Cure for Diabetes and its Complications in Pets, Englsih|

How is the safety evaluation of the new drug conducted?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications in Pets, Englsih|

What are the main challenges in developing new drugs for pets?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications in Pets, Englsih|

What are the current challenges in treating diabetes in pets?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications in Pets, Englsih|

What is the mechanism of action of the new drug?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications in Pets, Englsih|

What is the purpose of developing the new drug?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications in Pets, Englsih|

KIYAN Group and Collaborating Research Institutions

KIYAN PHARMA Co., Ltd.

KIYAN MEDICAL Co., Ltd.

Biozipcode, Inc.

Shiga University of Medical Science, Dep. of Regenerative Medicine

Biozipcode, Inc.

We aim to completely cure diseases rather than just offering symptomatic treatments. We focus on developing a cure for diabetes and a technology that delivers medication to specific cells (cell targeting technology called “Biozipcode”).

Learn More About Us

Contact Us

Biozipcode, Inc.

TEL:
+81-50-5534-7865

E-MAIL:
info@biozipcode.com

ADDRESS:
Seta Tsukiwa-cho, Otsu City, Shiga Prefecture
Biomedical Innovation Center, Shiga University of Medical Science, 520-2121

Languages

© Copyright 2024 Biozipcode, Inc. All Rights Reserved.